La bourse est fermée

Koninklijke Philips N.V. (RYLPF)

Other OTC - Other OTC Prix différé. Devise en USD
Ajouter à la liste dynamique
20,15-0,09 (-0,42 %)
À la clôture : 11:27AM EDT

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam 1096 BC
Netherlands
31 20 597 7777
https://www.philips.com

Secteur(s)Healthcare
Secteur d’activitéMedical Devices
Employés à temps plein69 656

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Roy JakobsPresident, CEO & Chairman of the Board of Management3,91MS.O.1974
Dr. Paulus A. Stoffels M.D., Ph.D.Independent Vice Chairman of Supervisory Board & Secretary186,6kS.O.1962
Mr. Abhijit BhattacharyaExecutive VP, CFO & Member of the Board of Management2,39MS.O.1961
Mr. Marnix J. van GinnekenExecutive VP, Chief ESG, Legal Officer & Member of the Board of Management1,83MS.O.1973
Mr. Willem AppeloExecutive VP & COOS.O.S.O.1964
Mr. Leandro MazzoniHead of Investor RelationsS.O.S.O.S.O.
Heidi SichienExecutive VP & Chief People OfficerS.O.S.O.1974
Mr. Andy HoExecutive VP & Chief Market Leader of Philips Greater ChinaS.O.S.O.1961
Jan KimpenChief Medical OfficerS.O.S.O.1958
Mr. Pim PreesmanCountry Leader/ Health Systems Leader IndonesiaS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Koninklijke Philips N.V. en date du 1 mars 2024 est 3. Les scores principaux sont Audit : 1; Société : 1; Droits des actionnaires : 5; Compensation : 6.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.